Menu

  • Cardiac Surgery
  • Education and Resources

    • All in on ECMO

    Providing products designed specifically for ECMO and a wide breadth of support products that can be used with patients in critical care settings

    • Collaborating with clinical teams, hospital systems, and societies to optimize and simplify technologies and processes
    • Supporting evidence generation and excellence in education
       
    This is an image of the VitalFlow™ extracorporeal membrane oxygenation (ECMO) system.

    ECMO system

    Designed for simplicity and performance, the VitalFlow™ ECMO system can be configured to accommodate your clinical preferences and hospital protocols.1

    This is an image of the Nautilus™ Smart extracorporeal membrane oxygenator (ECMO) module.

    ECMO oxygenators

    Innovative flow-path design and real-time device diagnostic capabilities — designed for long-term performance.†,2

    This is an image of the Bio-Medicus Life Support™ catheter and introducer.

    ECMO access solutions

    Catheters designed for the duration and support requirements of patients on VV and/or VA ECMO3

    ECMO stories

    ECMO patient stories

    Ben’s journey from ECMO to Ironman finisher

    Carlos and Grace’s COVID-19 journey — from ECMO to marriage

    ECMO clinical stories

    Starting an ECMO center

    Medtronic Cardiac Surgery

    With every beat, expect more.

    Medtronic Academy

    Find additional feature information along with a variety of educational resources and tools.

    Resources

    Potential complications related to the use of ECMO devices include, but are not limited to, heart, vessel, or lung damage, hypoxia, anemia, irritation, toxic reaction, infection, hemorrhage, liver or kidney failure, stroke, and death. The benefits of extracorporeal support must be weighed against the risk of systemic anticoagulation and must be assessed by the prescribing physician.

    The benefits of catheterization for extracorporeal circulation must be weighed against the risk of systemic anticoagulation and subsequent propensity for hemorrhage.

    † Indicated in the United States for use up to 48 hours.

    1. Medtronic design verification data on file. Data may not be indicative of clinical performance.

    2. Data on file. Design verification and validation reports. These tests may not be indicative of clinical performance.

    3. Data on file. Design verification report. These tests may not be indicative of clinical performance.